Generation and biological characterization of a neutralization-resistant mutant of Newcastle disease virus

Journal of Bacteriology and Virology

Volumn 42, Issue 4, 2012, Pages 330-338

  Park, Mi Ja ^a   Kye, Soo Jeong ^a   Kim, Ji Ye ^a   Kim, Saeromi ^a   Seul, Hee Jung ^a   Park, Choi Kyu ^a   Choi, Kang Seuk ^a  

^a Animal Plant and Fisheries Quarantine and Inspection Agency   (South Korea)

Author keywords

HN protein; Neuraminidase activity; Neutralization resistant escape mutant; Newcastle disease virus

Indexed keywords

HN PROTEIN; MONOCLONAL ANTIBODY;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CHICKEN; CONTROLLED STUDY; ELUTION; ENZYME ACTIVITY; FIBROBLAST; GENE MUTATION; GENE SEQUENCE; HEMADSORPTION; NEUTRALIZATION RESISTANT MUTANT; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOTYPE; VIROGENESIS; VIRUS GENE; VIRUS MUTANT; VIRUS NEUTRALIZATION; VIRUS RELEASE; VIRUS TITRATION; VIRUS VIRULENCE;

EID: 84922687004     PISSN: 15982467     EISSN: None     Source Type: Journal    
DOI: 10.4167/jbv.2012.42.4.330     Document Type: Article

References (34)

1. De leeuw O, Peeters B. Complete nucleotide sequence of Newcastle disease virus: evidence for the existence of a new genus within the subfamily Paramyxovirinae. J Gen Virol 1999;80:131-6.
2. Mayo MA. A summary of taxonomic changes recently approved by ICTV. Arch Virol 2002;147:1655-63.
3. Connaris H, Takimoto T, Russell R, Crennell S, Moustafa I, Portner A, et al. Probing the sialic acid binding site of the hemagglutinin-neuraminidase of Newcastle disease virus: identification of key amino acids involved in cell binding, catalysis, and fusion. J Virol 2002;76:1816-24.
4. Crennell S, Takimoto T, Portner A, Taylor G. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat Struct Biol 2000;7: 1068-74.
5. Palermo LM, Porotto M, Greengard O, Moscona A. Fusion promotion by a paramyxovirus hemagglutininneuraminidase protein: pH modulation of receptor avidity of binding sites I and II. J Virol 2007;81:9152-61.
6. Panda A, Huang Z, Elankumaran S, Rockemann DD, Samal SK. Role of fusion protein cleavage site in the virulence of Newcastle disease virus. Microb Pathog 2004;36:1-10.
7. Ke GM, Yu SW, Ho CH, Chu PY, Ke LY, Lin KH, et al. Characterization of newly emerging Newcastle disease viruses isolated during 2002-2008 in Taiwan. Virus Res 2010;147:247-57.
8. Iorio RM, Syddall RJ, Sheehan JP, Bratt MA, Glickman RL, Riel AM. Neutralization map of the hemagglutininneuraminidase glycoprotein of Newcastle disease virus: domains recognized by monoclonal antibodies that prevent receptor recognition. J Virol 1991;65:4999-5006.
9. Cho SH, Kwon HJ, Kim TE, Kim JH, Yoo HS, Kim SJ. Variation of a Newcastle disease virus hemagglutininneuraminidase linear epitope. J Clin Microbiol 2008; 46:1541-4.
10. Gu M, Liu W, Xu L, Cao Y, Yao C, Hu S, et al. Positive selection in the hemagglutinin-neuraminidase gene of Newcastle disease virus and its effect on vaccine efficacy. Virol J 2011;8:150.
11. Hu S, Wang T, Liu Y, Meng C, Wang X, Wu Y, et al. Identification of a variable epitope on the Newcastle disease virus hemagglutinin-neuraminidase protein. Vet Microbiol 2010;140:92-7.
12. Huang Y, Wan HQ, Liu HQ, Wu YT, Liu XF. Genomic sequence of an isolate of Newcastle disease virus isolated from an outbreak in geese: a novel six nucleotide insertion in the non-coding region of the nucleoprotein gene. Brief Report. Arch Virol 2004;149: 1445-57.
13. Liang R, Cao DJ, Li JQ, Chen J, Guo X, Zhuang FF, et al. Newcastle disease outbreaks in western China were caused by the genotypes VIIa and VIII. Vet Microbiol 2002;87:193-203.
14. Lin MY, Liu HJ, Ke GM. Genetic and antigenic analysis of Newcastle disease viruses from recent outbreaks in Taiwan. Avian Pathol 2003;32:345-50.
15. Miller PJ, King DJ, Afonso CL, Suarez DL. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge. Vaccine 2007; 25:7238-46.
16. Tsai HJ, Chang KH, Tseng CH, Frost KM, Manvell RJ, Alexander DJ. Antigenic and genotypical characterization of Newcastle disease viruses isolated in Taiwan between 1969 and 1996. Vet Microbiol 2004;104:19-30.
17. Yu L, Wang Z, Jiang Y, Chang L, Kwang J. Characterization of newly emerging Newcastle disease virus isolates from the People's Republic of China and Taiwan. J Clin Microbiol 2001;39:3512-9.
18. Lee YJ, Sung HW, Choi JG, Kim JH, Song CS. Molecular epidemiology of Newcastle disease viruses isolated in South Korea using sequencing of the fusion protein cleavage site region and phylogenetic relationships. Avian Pathol 2004;33:482-91.
19. Lee, YJ, Sung HW, Choi JG, Lee EK, Yoon H, Kim JH, et al. Protection of chickens from Newcastle disease with a recombinant baculovirus subunit vaccine expressing the fusion and hemagglutinin neuraminidase proteins. J Vet Sci 2008;9:301-8.
20. Choi KS, Nah JJ, Ko YJ, Choi CU, Kim JH, Kang SY, et al. Characterization of antigenic sites on the rinderpest virus N protein using monoclonal antibodies. J Vet Sci 2003;4:57-65.
21. Tsunekun R, Ito H, Kida H, Otsuki K, Ito T. Increase in the neuraminidase activity of a nonpathogenic Newcastle disease virus isolate during passaging in chickens. J Vet Med Sci 2010;72:453-7.
22. Bousse TL, Taylor G, Krishnamurthy S, Portner A, Samal SK, Takimoto T. Biological significance of the second receptor binding site of Newcastle disease virus hemagglutinin-neuraminidase protein. J Virol 2004;78: 13351-5.
23. Alexander DJ. Newcastle disease. In: Purchase HG, Arp LH, Domermuth CH, Pearson JE, editors. A laboratory manual for the isolation and identification of avian pathogens. 3rd ed. American Association for Avian Pathologists; 1990. p. 114-20.
24. Reed LH, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938;27:493-7.
25. Iorio RM, Glickman RL. Fusion Mutants of Newcastle Disease Virus Selected with Monoclonal Antibodies to the Hemagglutinin-Neuraminidase. J Virol 1992;66: 6626-33.
26. Takimoto T, Taylor GL, Connaris HC, Crennell SJ, Portner A. Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion. J Virol 2002;76:13028-33.
27. Gravel KA, Morrison TG. Interacting Domains of the HN and F Proteins of Newcastle Disease Virus. J Virol 2003;77:11040-9.
28. Heminway BR, Yu Y, Galinski MS. Paramyxovirus mediated cell fusion requires co-expression of both the fusion and hemagglutinin-neuraminidase glycoproteins. Virus Res 1994;31:1-16.
29. Horvath CM, Paterson RG, Shaughnessy MA, Wood R, Lamb RA. Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia. J Virol 1992;66:4564-9.
30. Melanson VR, Iorio RM. Amino acid substitutions in the F-Specific domain in the stalk of the Newcastle disease virus HN protein modulate fusion and interfere with Its interaction with the F protein. J Virol 2004; 78:13053-61.
31. Khattar SK, Yan Y, Panda A, Collins PL, Samal SK. A Y526Q mutation in the Newcastle disease virus HN protein reduces its functional activities and attenuates virus replication and pathogenicity. J Virol 2009;83: 7779-82.
32. Römer-Oberdörfer A, Veits J, Werner O, Mettenleiter TC. Enhancement of pathogenicity of Newcastle disease virus by alteration of specific amino acid residues in the surface glycoproteins F and HN. Avian Dis 2006; 50:259-63.
33. Nagai Y, Klenk HD, Rott R. Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology 1976;72:494-508.
34. Dortmans JC, Rottier PJ, Koch G, Peeters BP. Passaging of a Newcastle disease virus pigeon variant in chickens results in selection of viruses with mutations in the polymerase complex enhancing virus replication and virulence. J Gen Virol 2011;92:336-45.